Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "trial" return 19 results.
SWINE VETERINARY SERVICES SPECIALIST >
Join us as SWINE VETERINARY SERVICES SPECIALIST in SOUTHERN market, Vietnam
Business and scientific partnerships >
By fostering partnerships with universities, institutes, private and public research centres, Ceva is not only able to keep up with the latest advances in research, but also to expand and diversify sc...
C.H.I.C.K. Program Online - No.20 >
Basic aspects of in-ovo injection in commercial hatcheries
Vectormune® ND - New concept for redefining ND vaccination program >
VECTORMUNE® ND is able to bring to the industry strong advantages in both low and high challenge countries for Newcastle disease. This is a Ceva innovative vaccine that protects against both Newcastle...
EGGS Program Online - No.06 >
Quality of intramuscular injection
CEVAC® CORYMUNE 4K & 7K >
Benefits Beyond Protection
Hyogen® with ImuvantTM - Superior Protection Against Mycoplasma hyopneumoniae infection >
- Single injection provides early and long lasting protection - Broad stimulation of the immune system with ImuvantTM - Trials demonstrate superior protection versus competitors - Expertise of the...
C.H.I.C.K. Program Online - No.17 >
Vaccination in the hatchery - The assurance of a good start
Coglapix® - Economic benefit study versus an antibiotic in the control of A.P. >
The Vaccine group (with Coglapix®) and Antibiotic group have the higher performance and more profit than the Control group. Although the similar performance, the economic impact given by the Vaccine g...
APP: Comparison Of Four Different Vaccines Under Field Conditions In The Philippines >
A trial under field conditions has been conducted in the Philippines in comparison Coglapix® with two toxoid vaccines and one bacterin vaccine of the market. In this trial, Coglapix®, the toxoid vacci...